Publications

2023

Gilloteaux J, De Swert K, Suain V, Nicaise C. Thalamic Neuron Resilience during Osmotic Demyelination Syndrome (ODS) Is Revealed by Primary Cilium Outgrowth and ADP-ribosylation factor-like protein 13B Labeling in Axon Initial Segment. Int J Mol Sci. 2023 Nov 17;24(22):16448.

Mignolet M, Gilloteaux J, Halloin N, Gueibe M, Willemart K, De Swert K, Bielarz V, Suain V, Pastushenko I, Gillet NA, Nicaise C. Viral Entry Inhibitors Protect against SARS-CoV-2-Induced Neurite Shortening in Differentiated SH-SY5Y Cells. Viruses. 2023; 15(10):2020.

Gilloteaux J, De Swert K, Suain V, Brion JP, Nicaise C. Loss of Ephaptic Contacts in the Murine Thalamus during Osmotic Demyelination Syndrome. Ultrastruct Pathol. 2023 Jul 21:1-26.

Lefebvre-Omar C, Liu E, Dalle C, d'Incamps BL, Bigou S, Daube C, Karpf L, Davenne M, Robil N, Jost Mousseau C, Blanchard S, Tournaire G, Nicaise C, Salachas F, Lacomblez L, Seilhean D, Lobsiger CS, Millecamps S, Boillée S, Bohl D. Neurofilament accumulations in amyotrophic lateral sclerosis patients' motor neurons impair axonal initial segment integrity. Cell Mol Life Sci. 2023 May 15;80(6):150.

Maugeri L, Jankovski A, Malucelli E, Mangini F, Vandeweerd JM, Gilloteaux J, De Swert K, Brun F, Begani Provinciali G, DiNuzzo M, Mittone A, Bravin A, Gigli G, Giove F, Cedola A, Nicaise C, Fratini M. Lesion extension and neuronal loss following spinal cord injury using X-ray phase-contrast tomography in mice. J Neurotrauma. 2023 May;40(9-10):939-951.

2022

Bertoglio D, Halloin N, Lombaerde S, Jankovski A, Verhaeghe J, Nicaise C, Staelens S. SV2A PET imaging is a non-invasive marker for the detection of spinal damages in experimental models of spinal cord injury. J Nucl Med. 2022 Aug;63(8):1245-1251.

Moreau A, Nicaise C, Awada A, Soyfoo MS. Soluble ST2 is increased in systemic lupus erythematous and is a potential marker of lupus nephritis. Clin Exp Rheumatol. 2022 May;40(5):897-903.

2021

Gilloteaux J, Bouchat J, Bielarz V, Brion JP, Nicaise C. A primary cilium in oligodendrocytes: a fine structure signal of repairs in thalamic Osmotic Demyelination Syndrome (ODS). Ultrastruct Pathol. 2021 Mar 4;45(2):128-157.

Sprimont L, Janssen P, De Swert K, Van Bulck M, Rooman I, Gilloteaux J, Massie A, Nicaise C. Cystine-glutamate antiporter deletion accelerates motor recovery and improves histological outcomes following spinal cord injury in mice. Sci Rep. 2021 Jun 9;11(1):12227.

Verbruggen L, Sprimont L, Bentea E, Janssen P, Gharib A, Deneyer L, De Pauw L, Lara O, Sato H, Nicaise C, Massie A. Chronic Sulfasalazine Treatment in Mice Induces System xc^- - Independent Adverse Effects. Front Pharmacol. 2021 May 18;12:625699.

Bielarz V, Willemart K, Avalosse N, De Swert K, Lotfi R, Lejeune N, Poulain F, Ninanne N, Gilloteaux J, Gillet N, Nicaise C. Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection. Brain Res. 2021 Feb 5:147344.

Scalisi J, Balau B, Deneyer L, Bouchat J, Gilloteaux J, Nicaise C. Blood-brain barrier permeability towards small and large tracers in a mouse model of osmotic demyelination syndrome. Neurosci Lett. 2021 Feb 16;746:135665.

Soyfoo MS, Nicaise C. Pathophysiologic role of Interleukin-33/ST2 in Sjögren's syndrome. Autoimmun Rev. 2021 Mar;20(3):102756.

Miocchi P, Sierra A, Maugeri L, Stefanutti E, Abdollahzadeh A, Mangini F, Moraschi M, Bukreeva I, Massimi L, Brun F, Tohka J, Gröhn O, Mittone A, Bravin A, Nicaise C, Giove F, Cedola A, Fratini M. Steerable3D: An ImageJ plugin for neurovascular enhancement in 3-D segmentation. Phys Med. 2021 Jan 17;81:197-209.

2020

Gilloteaux J, Bouchat J, Brion JP, Nicaise C. The osmotic demyelination syndrome: the resilience of thalamic neurons is verified with transmission electron microscopy. Ultrastruct Pathol. 2020 Nov 20;44(4-6):450-480.

Hamdan N, Mehawej C, Sebaaly G, Jalkh N, Corbani S, Abou-Ghoch J, De Backer O, Chouery E. A homozygous stop gain mutation in BOD1 gene in a Lebanese patient with syndromic intellectual disability. Clin Genet. 2020 Sep;98(3):288-292.

2019

Bouchat J, Gilloteaux J, Suain V, Van Vlaender D, Brion JP, Nicaise C. Ultrastructural Analysis of Thalamus Damages in a Mouse Model of Osmotic-Induced Demyelination. Neurotox Res. 2019 Jul;36(1):144-162.

Nicaise C, Marneffe C, Bouchat J, Gilloteaux J. Osmotic Demyelination: From an Oligodendrocyte to an Astrocyte Perspective. Int J Mol Sci. 2019 Mar 5;20(5).

Raas Q, Saih FE, Gondcaille C, Trompier D, Hamon Y, Leoni V, Caccia C, Nasser B, Jadot M, Ménétrier F, Lizard G, Cherkaoui-Malki M, Andreoletti P, Savary S. A microglial cell model for acyl-CoA oxidase 1 deficiency. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Apr;1864(4):567-576.

2018

Maugeri L, DiNuzzo M, Moraschi M, Nicaise C, Bukreeva I, Mangini F, Giove F, Cedola A, Fratini M. Fractal Dimension Analysis of High-Resolution X-Ray Phase Contrast Micro-Tomography Images at Different Threshold Levels in a Mouse Spinal Cord. 2018 Condensed Matter 3(4), 48

Gilloteaux J, Subramanian K, Solomon N, Nicaise C. The leptin receptor mutation of the obese Zucker rat causes sciatic nerve demyelination with a centripetal pattern defect. Ultrastruct Pathol. 2018 Sep-Oct;42(5):377-408.

Vatzaki E, Straus S, Dogne JM, Garcia Burgos J, Girard T, Martelletti P. Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation. J Headache Pain. 2018 Aug 14;19(1):68.

De Backer JF, Monlezun S, Detraux B, Gazan A, Vanopdenbosch L, Cheron J, Cannazza G, Valverde S, Cantacorps L, Nassar M, Venance L, Valverde O, Faure P, Zoli M, De Backer O, Gall D, Schiffmann SN, de Kerchove d'Exaerde A. Deletion of Maged1 in mice abolishes locomotor and reinforcing effects of cocaine. EMBO Rep. 2018 Sep;19(9).

Vandeweerd JM, Hontoir F, De Knoop A, De Swert K, Nicaise C. Retrograde Neuroanatomical Tracing of Phrenic Motor Neurons in Mice. J Vis Exp. 2018 Feb 22;(132).

Bouchat J, Couturier B, Marneffe C, Gankam-Kengne F, Balau B, De Swert K, Brion JP, Poncelet L, Gilloteaux J, Nicaise C. Regional oligodendrocytopathy and astrocytopathy precede myelin loss and blood-brain barrier disruption in a murine model of osmotic demyelination syndrome. Glia. 2018 Mar;66(3):606-622.

2016

Bohl D, Pochet R, Mitrecic D, Nicaise C. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology. Curr Stem Cell Res Ther. 2016;11(4):301-12.

2015

Pochet R, Nicaise C, Mitrečić D. Translation of the focus toward excellence in translational science: comment on "TDP-43 Repression of Nonconserved Cryptic Exons is Compromised in ALS-FTD". Croat Med J. 2015 Oct 31;56(5):493-5.

Nicaise C, Mitrecic D, Falnikar A, Lepore AC. Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury. World J Stem Cells. 2015 Mar 26;7(2):380-98.

Zheng M, Zhang H, Dill DL, Clark JD, Tu S, Yablonovitch AL, Tan MH, Zhang R, Rujescu D, Wu M, Tessarollo L, Vieira W, Gottesman MM, Deng S, Eberlin LS, Zare RN, Billard JM, Gillet JP, Li JB, Peltz G. The role of Abcb5 alleles in susceptibility to haloperidol-induced toxicity in mice and humans. PLoS Med. 2015 Feb 3;12(2):e1001782.

2014

Li K, Nicaise C, Sannie D, Hala TJ, Javed E, Parker JL, Putatunda R, Regan KA, Suain V, Brion JP, Rhoderick F, Wright MC, Poulsen DJ, Lepore AC. Overexpression of the astrocyte glutamate transporter GLT1 exacerbates phrenic motor neuron degeneration, diaphragm compromise, and forelimb motor dysfunction following cervical contusion spinal cord injury. The Journal of neuroscience : the official journal of the Society for Neuroscience 2014, 34:7622-7638.

Allard J, Li K, Lopez XM, Blanchard S, Barbot P, Rorive S, Decaestecker C, Pochet R, Bohl D, Lepore AC, Salmon I, Nicaise C. Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells. Regen Med. 2014;9(4):437-52.